Recently, I attended the 2026 PCMG meeting, where I had the opportunity to hear Petra Van Vlierberghe of argenx share invaluable insights on scaling and innovation in clinical development....
Continue Reading
Recently, I attended the 2026 PCMG meeting, where I had the opportunity to hear Petra Van Vlierberghe of argenx share invaluable insights on scaling and innovation in clinical development....
Continue Reading
As global demand for GMP manufacturing capacity has grown, the life sciences industry has experienced a significant wave of construction, expansion, and operational scale-up across...
Continue Reading
Clinical Research / Monitoring
Outsourcing has become an essential part of modern clinical development, but not all outsourcing models serve the same purpose. As pipelines diversify and trial designs grow more complex,...
Continue Reading
Clinical Research / Monitoring Clinical Staffing
As clinical development becomes more demanding, Sponsors are under pressure to deliver high‑quality studies with greater speed, precision, and efficiency. The Functional Service Provider...
Continue Reading
Clinical Research / Monitoring
Clinical development is evolving at a pace that challenges traditional outsourcing models. As pipelines expand and trial designs grow more complex, Sponsors are looking for ways to stay...
Continue Reading
In 2010, launching a Phase III oncology study required approximately 769 steps, 36 approvals, and took a median of 2.5 years.1 Since then, clinical trials have only become more complex,...
Continue Reading